Barclays’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$619K Sell
27,803
-340,501
-92% -$8.14M ﹤0.01% 3060
2025
Q4
$9.84M Sell
368,304
-66,682
-15% -$1.59M ﹤0.01% 1686
2025
Q3
$9.28M Buy
434,986
+7,513
+2% +$178K ﹤0.01% 1720
2025
Q2
$9.22M Buy
427,473
+179,025
+72% +$3.33M ﹤0.01% 1645
2025
Q1
$4.13M Sell
248,448
-49,997
-17% -$908K ﹤0.01% 2063
2024
Q4
$5.48M Buy
298,445
+20,880
+8% +$337K ﹤0.01% 2070
2024
Q3
$4.27M Buy
277,565
+154,854
+126% +$2.58M ﹤0.01% 2226
2024
Q2
$1.99M Sell
122,711
-9,133
-7% -$147K ﹤0.01% 2149
2024
Q1
$2.44M Sell
131,844
-214,959
-62% -$5.33M ﹤0.01% 2404
2023
Q4
$10.9M Buy
346,803
+129,533
+60% +$3.09M 0.01% 1456
2023
Q3
$4.53M Buy
217,270
+27,730
+15% +$753K ﹤0.01% 1374
2023
Q2
$4.54M Buy
189,540
+23,862
+14% +$530K ﹤0.01% 1407
2023
Q1
$3.12M Sell
165,678
-145,531
-47% -$2.77M ﹤0.01% 1876
2022
Q4
$4.95M Sell
311,209
-15,838
-5% -$248K ﹤0.01% 1642
2022
Q3
$5.35M Buy
327,047
+221,781
+211% +$3.59M 0.01% 1118
2022
Q2
$1.48M Buy
105,266
+29,280
+39% +$546K ﹤0.01% 2061
2022
Q1
$1.84M Sell
75,986
-86,352
-53% -$2.09M ﹤0.01% 1927
2021
Q4
$3.79M Buy
162,338
+59,386
+58% +$1.19M ﹤0.01% 1911
2021
Q3
$1.71M Buy
102,952
+20,049
+24% +$386K ﹤0.01% 2451
2021
Q2
$2.02M Buy
82,903
+14,624
+21% +$330K ﹤0.01% 2186
2021
Q1
$1.76M Buy
68,279
+26,295
+63% +$1.16M ﹤0.01% 2392
2020
Q4
$2.25M Sell
41,984
-15,517
-27% -$770K ﹤0.01% 2146
2020
Q3
$2.37M Sell
57,501
-107,362
-65% -$4.64M ﹤0.01% 1957
2020
Q2
$7.99M Buy
164,863
+58,072
+54% +$2.79M 0.01% 1085
2020
Q1
$4.51M Sell
106,791
-147,754
-58% -$6.09M 0.01% 1550
2019
Q4
$10.9M Sell
254,545
-48,733
-16% -$2.12M 0.01% 1336
2019
Q3
$10.9M Buy
303,278
+192,284
+173% +$5.83M 0.01% 1230
2019
Q2
$2.97M Buy
110,994
+6,442
+6% +$165K ﹤0.01% 2453
2019
Q1
$2.81M Sell
104,552
-96,932
-48% -$2.26M ﹤0.01% 2207
2018
Q4
$3.26M Sell
201,484
-243,079
-55% -$4.72M 0.01% 1926
2018
Q3
$9.23M Buy
444,563
+346,025
+351% +$5.44M 0.01% 1311
2018
Q2
$1.5M Buy
98,538
+32,427
+49% +$578K ﹤0.01% 2839
2018
Q1
$1.48M Sell
66,111
-31,040
-32% -$859K ﹤0.01% 2770
2017
Q4
$2.92M Sell
97,151
-58,660
-38% -$1.88M ﹤0.01% 2092
2017
Q3
$5.87M Sell
155,811
-26,893
-15% -$875K 0.01% 1414
2017
Q2
$5.09M Buy
182,704
+61,114
+50% +$1.82M 0.01% 1462
2017
Q1
$4.18M Sell
121,590
-10,356
-8% -$366K 0.01% 1459
2016
Q4
$3.81M Buy
131,946
+46,230
+54% +$1.22M 0.01% 1577
2016
Q3
$2.73M Sell
85,716
-7,372
-8% -$250K 0.01% 1738
2016
Q2
$3.02M Sell
93,088
-86,384
-48% -$2.89M 0.01% 1685
2016
Q1
$4.84M Buy
179,472
+178,130
+13,273% +$3.88M 0.02% 1195
2015
Q4
$47K Sell
1,342
-26,712
-95% -$941K ﹤0.01% 4828
2015
Q3
$926K Buy
28,054
+26,508
+1,715% +$1.1M ﹤0.01% 2784
2015
Q2
$63K Sell
1,546
-1,771
-53% -$68.5K ﹤0.01% 4999
2015
Q1
$106K Sell
3,317
-48,337
-94% -$1.66M ﹤0.01% 4805
2014
Q4
$1.6M Sell
51,654
-4,192
-8% -$119K ﹤0.01% 2729
2014
Q3
$1.34M Buy
55,846
+31,022
+125% +$726K ﹤0.01% 3040
2014
Q2
$547K Sell
24,824
-27,800
-53% -$580K ﹤0.01% 3886
2014
Q1
$1.26M Sell
52,624
-74,320
-59% -$1.88M ﹤0.01% 2990
2013
Q4
$3.05M Buy
126,944
+35,511
+39% +$838K 0.01% 2250
2013
Q3
$2.47M Buy
91,433
+52,696
+136% +$1.1M 0.01% 2343
2013
Q2
$703K Buy
+38,737
New +$534K ﹤0.01% 3809

Other funds holding ACAD